Detalhe da pesquisa
1.
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
Cell
; 184(16): 4203-4219.e32, 2021 08 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34242577
2.
Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.
Cell
; 184(11): 2955-2972.e25, 2021 05 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34019795
3.
Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1.
J Virol
; 87(8): 4185-201, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23365441
4.
HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages.
J Virol
; 86(14): 7496-507, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22553329
5.
Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes.
bioRxiv
; 2023 Sep 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36909627
6.
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes.
Nat Commun
; 14(1): 7897, 2023 Nov 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38036525
7.
Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual.
J Virol
; 85(15): 7719-29, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21613396
8.
Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation.
J Virol
; 85(22): 11725-31, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-21917975
9.
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates.
bioRxiv
; 2021 Feb 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33442694
10.
Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations.
Nat Commun
; 8(1): 1732, 2017 11 23.
Artigo
Inglês
| MEDLINE | ID: mdl-29170366
11.
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site.
Cell Rep
; 14(1): 43-54, 2016 Jan 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26725118
12.
Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages.
Sci Transl Med
; 8(336): 336ra62, 2016 04 27.
Artigo
Inglês
| MEDLINE | ID: mdl-27122615
13.
Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus.
Nat Commun
; 7: 12131, 2016 07 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27381634
14.
Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques.
JCI Insight
; 1(20): e88522, 2016 12 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27942585
15.
HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies.
Science
; 349(6249): aab1253, 2015 Aug 14.
Artigo
Inglês
| MEDLINE | ID: mdl-26229114
16.
HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria.
Cell Host Microbe
; 16(2): 215-226, 2014 Aug 13.
Artigo
Inglês
| MEDLINE | ID: mdl-25121750
17.
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.
PLoS One
; 6(9): e23532, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21980336
18.
H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination.
PLoS One
; 6(10): e25797, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-22039424